Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

Ozempic contains the active ingredient semaglutide. Victoza contains the active ingredient liraglutide. Semaglutide and liraglutide belong to the same drug class, called glucagon-like peptide-1 ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

Ozempic is a prescription injection that’s FDA approved for use in adults with type 2 diabetes. It’s also prescribed off-label for weight loss. The drug belongs to a drug class called GLP-1 ...

Ozempic, Wegovy, and similar drugs mimic the ... But when they looked at drug classes separately, they found that GLP-1 drugs did appear to stand out from the rest. “In this meta-analysis ...

A groundbreaking daily pill could compete with weight-loss injections such as Ozempic, research suggests. In trials, people ...

You've probably heard of GLP-1s, a class of drugs that includes semaglutide (Ozempic). The drugs were developed to manage ...

Ozempic, made by Novo Nordisk, is part of a class of drugs known as GLP-1 agonists. The drugs are used to treat type 2 diabetes and obesity. The FDA said it was notified by Novo Nordisk about the ...